Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-065948
Filing Date
2017-12-15
Accepted
2017-12-15 16:35:12
Documents
2
Period of Report
2017-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3715
2 POA DOCUMENT poa.txt EX-24.4_757246 3291
  Complete submission text file 0001209191-17-065948.txt   8325
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 BONN PLACE WEEHAWKEN NJ 70886
Business Address
Garen Jonathan (Reporting) CIK: 0001693817 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 171259395